192 related articles for article (PubMed ID: 22577234)
41. Targeting of tetrathiomolybdate on the copper accumulating in the liver of LEC rats.
Ogra Y; Suzuki KT
J Inorg Biochem; 1998 Apr; 70(1):49-55. PubMed ID: 9661287
[TBL] [Abstract][Full Text] [Related]
42. Gene expression in the liver of Long-Evans cinnamon rats during the development of hepatitis.
Klein D; Lichtmannegger J; Finckh M; Summer KH
Arch Toxicol; 2003 Oct; 77(10):568-75. PubMed ID: 14574444
[TBL] [Abstract][Full Text] [Related]
43. Abnormal hepatobiliary and circulating lipid metabolism in the Long-Evans Cinnamon rat model of Wilson's disease.
Levy E; Brunet S; Alvarez F; Seidman E; Bouchard G; Escobar E; Martin S
Life Sci; 2007 Mar; 80(16):1472-83. PubMed ID: 17303181
[TBL] [Abstract][Full Text] [Related]
44. Therapeutic potential of hepatocyte-like-cells converted from stem cells from human exfoliated deciduous teeth in fulminant Wilson's disease.
Fujiyoshi J; Yamaza H; Sonoda S; Yuniartha R; Ihara K; Nonaka K; Taguchi T; Ohga S; Yamaza T
Sci Rep; 2019 Feb; 9(1):1535. PubMed ID: 30733544
[TBL] [Abstract][Full Text] [Related]
45. Animal models of Wilson disease.
Medici V; Huster D
Handb Clin Neurol; 2017; 142():57-70. PubMed ID: 28433110
[TBL] [Abstract][Full Text] [Related]
46. Therapeutic effects of tetrathiomolybdate on hepatic dysfunction occurring naturally in Long-Evans Cinnamon (LEC) rats: a bona fide animal model for Wilson's disease.
Sugawara N; Lai YR; Sugawara C
Res Commun Mol Pathol Pharmacol; 1999 Feb; 103(2):177-87. PubMed ID: 10461684
[TBL] [Abstract][Full Text] [Related]
47. Dietary copper triggers onset of fulminant hepatitis in the Long-Evans cinnamon rat model.
Siaj R; Sauer V; Stöppeler S; Spiegel HU; Köhler G; Zibert A; Schmidt HH
World J Gastroenterol; 2012 Oct; 18(39):5542-50. PubMed ID: 23112546
[TBL] [Abstract][Full Text] [Related]
48. [Biological regulation of copper and selective removal of copper: therapy for Wilson disease and its molecular mechanism].
Suzuki KT; Ogura Y
Yakugaku Zasshi; 2000 Oct; 120(10):899-908. PubMed ID: 11082702
[TBL] [Abstract][Full Text] [Related]
49. Decrease in biliary excretion of copper in Long-Evans cinnamon (LEC) rats causing spontaneous hepatitis due to a gross accumulation of hepatic copper.
Sugawara N; Li D; Sugawara C; Miyake H
Res Commun Chem Pathol Pharmacol; 1993 Jul; 81(1):45-52. PubMed ID: 8210689
[TBL] [Abstract][Full Text] [Related]
50. In
Sharma Y; Liu J; Kristian KE; Follenzi A; Gupta S
Gene Expr; 2018 Dec; 19(1):15-24. PubMed ID: 30029699
[TBL] [Abstract][Full Text] [Related]
51. Comparison of disposition behavior and de-coppering effect of triethylenetetramine in animal model for Wilson's disease (Long-Evans Cinnamon rat) with normal Wistar rat.
Iseki K; Kobayashi M; Ohba A; Miyazaki K; Li Y; Togashi Y; Takeichi N
Biopharm Drug Dispos; 1992 May; 13(4):273-83. PubMed ID: 1600113
[TBL] [Abstract][Full Text] [Related]
52. Systemic dispositions of molybdenum and copper after tetrathiomolybdate injection in LEC rats.
Ogra Y; Ohmichi M; Suzuki KT
J Trace Elem Med Biol; 1995 Oct; 9(3):165-9. PubMed ID: 8605606
[TBL] [Abstract][Full Text] [Related]
53. Intrahepatic transplantation of normal hepatocytes prevents Wilson's disease in Long-Evans cinnamon rats.
Yoshida Y; Tokusashi Y; Lee GH; Ogawa K
Gastroenterology; 1996 Dec; 111(6):1654-60. PubMed ID: 8942746
[TBL] [Abstract][Full Text] [Related]
54. Increased polyploid incidence is associated with abnormal copper accumulation in the liver of LEC mutant rat.
Muramatsu Y; Yamada T; Moralejo DH; Mochizuki H; Sogawa K; Matsumoto K
Res Commun Mol Pathol Pharmacol; 2000; 107(1-2):129-36. PubMed ID: 11334362
[TBL] [Abstract][Full Text] [Related]
55. Positron emission tomography of copper metabolism in the Atp7b-/- knock-out mouse model of Wilson's disease.
Peng F; Lutsenko S; Sun X; Muzik O
Mol Imaging Biol; 2012 Feb; 14(1):70-8. PubMed ID: 21327972
[TBL] [Abstract][Full Text] [Related]
56. A copper deficient diet prevents hepatic copper accumulation and dysfunction in Long-Evans Cinnamon (LEC) rats with an abnormal copper metabolism and hereditary hepatitis.
Sugawara N; Sugawara C
Arch Toxicol; 1994; 69(2):137-40. PubMed ID: 7717863
[TBL] [Abstract][Full Text] [Related]
57. Imaging copper metabolism imbalance in Atp7b (-/-) knockout mouse model of Wilson's disease with PET-CT and orally administered 64CuCl2.
Peng F; Lutsenko S; Sun X; Muzik O
Mol Imaging Biol; 2012 Oct; 14(5):600-7. PubMed ID: 22170165
[TBL] [Abstract][Full Text] [Related]
58. Protection from spontaneous hepatocellular damage by N-benzyl-d-glucamine dithiocarbamate in Long-Evans Cinnamon rats, an animal model of Wilson's disease.
Shimada H; Takahashi M; Shimada A; Okawara T; Yasutake A; Imamura Y; Kiyozumi M
Toxicol Appl Pharmacol; 2005 Jan; 202(1):59-67. PubMed ID: 15589977
[TBL] [Abstract][Full Text] [Related]
59. Wilson's disease: a new gene and an animal model for an old disease.
Cuthbert JA
J Investig Med; 1995 Aug; 43(4):323-36. PubMed ID: 7552582
[TBL] [Abstract][Full Text] [Related]
60. Zinc supplementation decreases hepatic copper accumulation in LEC rat: a model of Wilson's disease.
Gonzalez BP; Niño Fong R; Gibson CJ; Fuentealba IC; Cherian MG
Biol Trace Elem Res; 2005; 105(1-3):117-34. PubMed ID: 16034158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
